Back to BlackRock, Inc. BlackRock, Inc.

ADCTADCT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ADC THERAPEUTICS SA

BlackRock, Inc. holds 7M shares of ADCT (ADC THERAPEUTICS SA), worth $7.5M as of 2026-Q2. The position was increased (+12.3% shares). ADCT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$7.5M

Current Shares

7M

Total Value Change

-$2.5M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7M
+12.3%
$7.5M0.0%$1.07
31
2026-Q1
Increased
6.3M
+15.2%
$23.4M0.0%$4.05
33
2025-Q4
Increased
5.4M
+20.3%
$19.2M0.0%$3.50
34
2025-Q3
Decreased
4.5M
-0.2%
$18M0.0%$4.02
0
2025-Q2
Decreased
4.5M
-8.0%
$12.1M0.0%$2.71
0
2025-Q1
Decreased
4.9M
-2.0%
$6.9M0.0%$1.49
0
2024-Q4
New
5M
-
$10M0.0%$1.90
38

Other major holders of ADCT: BAKER BROS. ADVISORS LP, ALLIANCEBERNSTEIN L.P., Magnetar Financial LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used